Figure 4

Graphic modelling of the cost-effectiveness analysis. Cost comparison between current practices which do not identify AHI (1a) and the implementation of a potential IP-10 rapid pre-screening test (1b) in seronegative febrile outpatients for AHI detection in a Sub-Saharan setting.